Cargando…
Gut microbiota mediated the therapeutic efficacies and the side effects of prednisone in the treatment of MRL/lpr mice
BACKGROUND: Growing evidences indicate that the alterations in gut microbiota are associated with the efficacy of glucocorticoids (GCs) in the treatment of systemic lupus erythematosus (SLE). However, there is no evidence to prove whether gut microbiota directly mediates the effects of GCs. METHODS:...
Autores principales: | Wang, Mingzhu, Zhu, Zhengyang, Lin, Xiaoying, Li, Haichang, Wen, Chengping, Bao, Jie, He, Zhixing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439074/ https://www.ncbi.nlm.nih.gov/pubmed/34521450 http://dx.doi.org/10.1186/s13075-021-02620-w |
Ejemplares similares
-
Alterations of the Gut Microbiota Associated With Promoting Efficacy of Prednisone by Bromofuranone in MRL/lpr Mice
por: He, Zhixing, et al.
Publicado: (2019) -
Early and Short-Term Interventions in the Gut Microbiota Affects Lupus Severity, Progression, and Treatment in MRL/lpr Mice
por: Zhang, Yun, et al.
Publicado: (2020) -
Metabolic Profiling Reveals an Abnormal Pattern of Serum Fatty Acids in MRL/lpr Mice Under Treatment With Prednisone
por: Li, Qianqian, et al.
Publicado: (2020) -
Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice.
por: Weinberg, J B
Publicado: (1998) -
Self-Reactivity and the Expression of Memory Markers
Vary Independently in MRL-Mp+/+ and MRL-Mp-lpr/lpr
Mice
por: Smyth, Lesley, et al.
Publicado: (1992)